MétaCan
Menu
← Back to cohort
Record W2416129579 · doi:10.1016/j.jalz.2015.06.650

P2‐112: Effects of citalopram on neuropsychiatric symptoms in Alzheimer's dementia: Evidence from the citad study

2015· article· en· W2416129579 on OpenAlexaff
Matthew E. Peters, Anne K. Leonpacher, Lea T. Drye, Kelly M. Makino, Davangere P. Devanand, Constantine Frangakis, Cynthia A. Munro, Jacobo Mintzer, Bruce G. Pollock, Paul B. Rosenberg, Lon S. Schneider, David Shade, Daniel Weintraub, Jerome A. Yesavage, Constantine G. Lyketsos, Anton P. Porsteinsson

Bibliographic record

VenueAlzheimer s & Dementia · 2015
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsCitalopramIrritabilityPlaceboAnxietyPsychologyDementiaAlzheimer's diseasePsychiatryDepression (economics)MedicineInternal medicineDiseaseAntidepressant

Abstract

fetched live from OpenAlex

Citalopram has been associated with improvement in agitation in patients with Alzheimer's disease. The objective of the present study was to evaluate whether other neuropsychiatric symptoms improved with citalopram treatment compared to placebo. In this planned secondary analysis of the Citalopram for Agitation in Alzheimer Disease (CitAD) study, we evaluated the effect of citalopram on the 12 neuropsychiatric symptom domains assessed on the Neuropsychiatric Inventory. We compared changes between baseline and week 9 on citalopram 30 mg/day vs. placebo with regard to the presence of individual neuropsychiatric symptoms and individual domain scores in participants with symptoms at baseline. At week 9, participants treated with citalopram were less likely to report delusions (OR=0.40, p=0.03), anxiety (OR=0.43, p=0.01), and irritability/lability (OR=0.38, p=0.01). When comparing median scores for participants with symptoms present at baseline, differences favoring citalopram were seen for hallucinations (p<0.01) and favoring placebo for sleep/nighttime behavior (p=0.03). While dose constraints must be considered due to its side effect profile, citalopram's overall therapeutic effects in patients with Alzheimer's disease and agitation include reduction in the frequency of irritability, anxiety, and delusions; reduction in the severity of hallucinations, but an increase in the severity of sleep/nighttime behavior.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.018

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.044
GPT teacher head0.327
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→